Literature DB >> 7888112

Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus.

A Bobkov1, R Cheingsong-Popov, M Garaev, A Rzhaninova, P Kaleebu, S Beddows, M H Bachmann, J I Mullins, J Louwagie, W Janssens.   

Abstract

OBJECTIVE: To identify HIV-1 envelope sequence subtypes in infected individuals from the Russian Federation and Belarus. PATIENTS: A cohort of children infected after exposure to non-sterile needles during the 1988-1989 HIV-1 epidemic in southern Russia (n = 20) and HIV-1-seropositive individuals from Russia (n = 1) and Belarus (n = 7) infected via sexual transmission.
METHODS: DNA samples derived from peripheral blood mononuclear cells were analysed for their HIV-1 genotypes by the heteroduplex mobility assay (HMA). The 1.3 kilobase-pair env gene fragments encoding a portion of gp120 were amplified by nested polymerase chain reaction, cloned and sequenced. The env sequences derived from these patients were aligned and phylogenetic neighbour-joining and maximum parsimony-derived trees generated.
RESULTS: The env sequences derived from eight individuals infected in Russia and Belarus belong to subtype A (one), B (four), C (two), and D (one). Sequences derived from children, infected during parenteral manipulations in southern Russia, and one mother were closely related, but highly divergent, as a group, from all prototypic strains (genetic divergence, 17.2-22.9%). However, they clustered together with env sequences of the V1525 and LBV21-7 isolates from Gabon, recently described to be members of a new HIV-1 env subtype G.
CONCLUSION: Extensive heterogeneity of HIV-1 subtypes was evident in the Russian Federation and Belarus. Our data also support the existence of an HIV-1 env genetic subtype G, and such isolates are now apparently present on both the African and European continents. These variants were identified through V3 peptide enzyme-linked immunosorbent assay screening and subsequent HMA analysis. The combination of these techniques represents a model for screening HIV variants within a large population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888112     DOI: 10.1097/00002030-199412000-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  21 in total

Review 1.  Primate immunodeficiency virus classification and nomenclature: Review.

Authors:  Brian T Foley; Thomas Leitner; Dimitrios Paraskevis; Martine Peeters
Journal:  Infect Genet Evol       Date:  2016-10-24       Impact factor: 3.342

2.  Short communication: Molecular epidemiology, phylogeny, and phylodynamics of CRF63_02A1, a recently originated HIV-1 circulating recombinant form spreading in Siberia.

Authors:  Nadezhda S Shcherbakova; Lyudmila A Shalamova; Elena Delgado; Aurora Fernández-García; Yolanda Vega; Larissa I Karpenko; Alexander A Ilyichev; Yuri V Sokolov; Dmitry N Shcherbakov; Lucía Pérez-Álvarez; Michael M Thomson
Journal:  AIDS Res Hum Retroviruses       Date:  2014-08-14       Impact factor: 2.205

3.  Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.

Authors:  F Gao; S G Morrison; D L Robertson; C L Thornton; S Craig; G Karlsson; J Sodroski; M Morgado; B Galvao-Castro; H von Briesen; S Beddows; J Weber; P M Sharp; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping.

Authors:  S M Agwale; K E Robbins; L Odama; A Saekhou; C Zeh; A Edubio; O M Njoku; N Sani-Gwarzo; M F Gboun; F Gao; M Reitz; D Hone; T M Folks; D Pieniazek; C Wambebe; M L Kalish
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

Review 5.  The HIV Epidemic: High-Income Countries.

Authors:  Sten H Vermund; Andrew J Leigh-Brown
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

6.  Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG.

Authors:  A Trkola; A B Pomales; H Yuan; B Korber; P J Maddon; G P Allaway; H Katinger; C F Barbas; D R Burton; D D Ho
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes.

Authors:  J P Moore; Y Cao; J Leu; L Qin; B Korber; D D Ho
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement.

Authors:  L G Kostrikis; Y Cao; H Ngai; J P Moore; D D Ho
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

Review 9.  HIV preventive vaccines. Progress to date.

Authors:  J Esparza; S Osmanov; W L Heyward
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

10.  Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I.

Authors:  L G Kostrikis; E Bagdades; Y Cao; L Zhang; D Dimitriou; D D Ho
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.